Roche to invest $50 billion in the U.S. as pharma tariff threat lingers
Headline from NBC 5 Dallas-Fort Worth
Swiss pharmaceutical giant Roche on Tuesday said that it would invest $50 billion in the United States.
NBC 5 Dallas-Fort Worth's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
GENEVA (AP) — Swiss pharmaceuticals powerhouse Roche announced Tuesday it plans to invest $50 billion in the United States over the next five years, creating 12,000 jobs.
Swiss drugmaker Roche said it plans to invest $50 billion in the U.S., the latest in a string of large companies boosting their presence in the country since President Donald Trump came into office.
The investment would go toward high-tech research and development sites and new manufacturing facilities in Indiana, California, Massachusetts and Pennsylvania.
The Basel-based company said the investment would go toward high-tech research and development sites and new manufacturing facilities in places including Massachusetts, California, Indiana, and Pennsylvania.
Roche will invest $50 billion over the next five years for new research and development sites across the US, including a new manufacturing facility in Indiana.
